Tricking bacteria into killing themselves
The CRISPR gene-editing technology could be used to target specific bacteria that cause fatal, drug-resistant infections in humans, according to MIT Technology Review.
Problem to be solved: Antibiotic-resistant bacteria are a danger to patients and lead to increased health care costs, according to the WHO. And more than 70% of the bacteria that cause infections in hospitals are resistant to at least one of the antibiotics usually used to treat them, per the FDA.
Eligo Biosciences in Paris and Locus Biosciences in North Carolina have started working on developing CRISPR-based antibiotics commercially.